by Crestone, Inc. | Sep 12, 2018 | Events
Crestone presents at Healthcare Capital and Connections Summit, Shanghai, China: CRS3123 for the Treatment of C. difficile Infection, and other Pipeline Programs
by Crestone, Inc. | Sep 4, 2018 | Events
ESCMID/ASM Conference Presentation Details Crestone presents a poster at ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance: Lead Development of PolC Polymerase Inhibitors against Resistant Gram‐positive...
by Crestone, Inc. | Jun 10, 2018 | Events
ASM Microbe 2018 Presentation Details Crestone presents an invited slide talk at ASM Microbe 2018 (Atlanta, GA) Optimization and Lead Selection of Benzothiazole Amide Analogs toward a Novel Antimycobacterial Agent. Link to...
by Crestone, Inc. | May 18, 2018 | Events
2018 NTM & Bronchiectasis Physician/Patient Presentation Details Crestone presents a poster on NTM drug development at the 2018 NTM & Bronchiectasis Physician/Patient Conference.
by Crestone, Inc. | Mar 11, 2018 | Events
Crestone presents a poster at New Antibacterial Discovery and Development Gordon Research Conference, Ventura Beach, CA: CRS3123, a novel drug candidate for the treatment of Clostridium difficile infection, is safe, well-tolerated and exhibits high intestinal levels...
